Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $612.56 | 4 | 49.4% |
| Food and Beverage | $581.77 | 14 | 46.9% |
| Education | $46.59 | 13 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $704.53 | 7 | $0 (2017) |
| QOL Medical, LLC | $146.77 | 1 | $0 (2017) |
| GENZYME CORPORATION | $125.00 | 1 | $0 (2023) |
| AbbVie, Inc. | $92.36 | 6 | $0 (2018) |
| Neurocrine Biosciences, Inc. | $91.69 | 1 | $0 (2024) |
| Retrophin, Inc. | $29.29 | 9 | $0 (2019) |
| Mylan Specialty L.P. | $19.72 | 1 | $0 (2017) |
| Travere Therapeutics, Inc. | $17.30 | 4 | $0 (2020) |
| Prometheus Laboratories Inc. | $14.26 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $91.69 | 1 | Neurocrine Biosciences, Inc. ($91.69) |
| 2023 | $125.00 | 1 | GENZYME CORPORATION ($125.00) |
| 2020 | $17.30 | 4 | Travere Therapeutics, Inc. ($17.30) |
| 2019 | $7.23 | 4 | Retrophin, Inc. ($7.23) |
| 2018 | $82.00 | 7 | AbbVie, Inc. ($50.44) |
| 2017 | $917.70 | 14 | Merck Sharp & Dohme Corporation ($704.53) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/03/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $91.69 | General |
| 10/06/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 01/21/2020 | Travere Therapeutics, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $7.82 | General |
| Category: Hepatology | ||||||
| 01/21/2020 | Travere Therapeutics, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $7.82 | General |
| Category: Hepatology | ||||||
| 01/21/2020 | Travere Therapeutics, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 01/21/2020 | Travere Therapeutics, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 10/21/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 09/13/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 04/11/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $4.74 | General |
| Category: Hepatology | ||||||
| 02/28/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 12/07/2018 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $4.74 | General |
| Category: Hepatology | ||||||
| 11/06/2018 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $4.74 | General |
| Category: Hepatology | ||||||
| 08/01/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Immunology | ||||||
| 05/17/2018 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $7.82 | General |
| Category: Hepatology | ||||||
| 05/09/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Immunology | ||||||
| 05/02/2018 | Prometheus Laboratories Inc. | — | Food and Beverage | In-kind items and services | $14.26 | General |
| 02/28/2018 | AbbVie, Inc. | Humira (Biological), Humira | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Immunology | ||||||
| 12/14/2017 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Travel and Lodging | Cash or cash equivalent | $53.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/29/2017 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $146.77 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/29/2017 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Food and Beverage | In-kind items and services | $34.96 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/28/2017 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Travel and Lodging | In-kind items and services | $272.23 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/28/2017 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Travel and Lodging | In-kind items and services | $151.13 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/28/2017 | Merck Sharp & Dohme Corporation | ZINPLAVA (Drug) | Travel and Lodging | In-kind items and services | $136.20 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/28/2017 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/28/2017 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: INFECTIOUS DISEASE | ||||||
About Dr. Jyoti Ramakrishna, M.D
Dr. Jyoti Ramakrishna, M.D is a Pediatric Gastroenterology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184606352.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jyoti Ramakrishna, M.D has received a total of $1,241 in payments from pharmaceutical and medical device companies, with $91.69 received in 2024. These payments were reported across 31 transactions from 9 companies. The most common payment nature is "Travel and Lodging" ($612.56).
Practice Information
- Specialty Pediatric Gastroenterology
- Location Boston, MA
- Active Since 11/15/2005
- Last Updated 07/24/2013
- Taxonomy Code 2080P0206X
- Entity Type Individual
- NPI Number 1184606352
Products in Payments
- ZINPLAVA (Biological) $568.33
- Sucraid (Drug) $146.77
- ZINPLAVA (Drug) $136.20
- Humira (Biological) $92.36
- (820) Cholbam (Drug) $46.59
- Epinephrine (Drug) $19.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Gastroenterology Doctors in Boston
Dr. Athos Bousvaros, Md, Mph, MD, MPH
Pediatric Gastroenterology — Payments: $64,436
Dr. Claire Zar-Kessler, Md, MD
Pediatric Gastroenterology — Payments: $52,051
Alessio Fasano, Md, MD
Pediatric Gastroenterology — Payments: $41,795
Maureen Jonas, Md, MD
Pediatric Gastroenterology — Payments: $27,311
Dr. Jocelyn Silvester, Md Phd, MD PHD
Pediatric Gastroenterology — Payments: $17,272
Dr. Samuel Nurko, Md, MD
Pediatric Gastroenterology — Payments: $17,160